Complete remission of scleromyxedema following autologous stem cell transplantation

Adrienne M. Feasel; Michele L. Donato; Madeleine Duvic

Complete remission of scleromyxedema following autologous stem cell transplantation

Adrienne M. Feasel
, Michele L. Donato
, Madeleine Duvic

School of Medicine

University of Texas Health Science Center at Houston

Research output: Contribution to journal › Article › peer-review

53 Scopus citations

Abstract

Scleromyxedema is characterized by dermal fibroblast proliferation and mucin deposition, associated with plasma cell dyscrasia. Therapy for systemic progression is often not effective, and the disease is potentially fatal. We describe a man with rapidly progressive scleromyxedema in whom multiple treatments had failed before complete remission was achieved with treatment with high-dose pulse dexamethasone, high-dose melphalan, and autologous stem cell transplantation.

Original language	English
Pages (from-to)	1071-1072
Number of pages	2
Journal	Archives of Dermatology
Volume	137
Issue number	8
State	Published - 2001

Cite this

@article{7b67979838d1432591044cef123e68a6,

title = "Complete remission of scleromyxedema following autologous stem cell transplantation",

abstract = "Scleromyxedema is characterized by dermal fibroblast proliferation and mucin deposition, associated with plasma cell dyscrasia. Therapy for systemic progression is often not effective, and the disease is potentially fatal. We describe a man with rapidly progressive scleromyxedema in whom multiple treatments had failed before complete remission was achieved with treatment with high-dose pulse dexamethasone, high-dose melphalan, and autologous stem cell transplantation.",

author = "Feasel, \{Adrienne M.\} and Donato, \{Michele L.\} and Madeleine Duvic",

year = "2001",

language = "English",

volume = "137",

pages = "1071--1072",

journal = "Archives of Dermatology",

issn = "0003-987X",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Complete remission of scleromyxedema following autologous stem cell transplantation

AU - Feasel, Adrienne M.

AU - Donato, Michele L.

AU - Duvic, Madeleine

PY - 2001

Y1 - 2001

N2 - Scleromyxedema is characterized by dermal fibroblast proliferation and mucin deposition, associated with plasma cell dyscrasia. Therapy for systemic progression is often not effective, and the disease is potentially fatal. We describe a man with rapidly progressive scleromyxedema in whom multiple treatments had failed before complete remission was achieved with treatment with high-dose pulse dexamethasone, high-dose melphalan, and autologous stem cell transplantation.

AB - Scleromyxedema is characterized by dermal fibroblast proliferation and mucin deposition, associated with plasma cell dyscrasia. Therapy for systemic progression is often not effective, and the disease is potentially fatal. We describe a man with rapidly progressive scleromyxedema in whom multiple treatments had failed before complete remission was achieved with treatment with high-dose pulse dexamethasone, high-dose melphalan, and autologous stem cell transplantation.

UR - https://www.scopus.com/pages/publications/0034878849

M3 - Article

C2 - 11493100

AN - SCOPUS:0034878849

SN - 0003-987X

VL - 137

SP - 1071

EP - 1072

JO - Archives of Dermatology

JF - Archives of Dermatology

IS - 8

ER -

Complete remission of scleromyxedema following autologous stem cell transplantation

Abstract

Other files and links

Fingerprint

Cite this